News | April 11, 2025
Orchid Pharma to settle disputes with DBS Bank
The company has entered into above Memo to settle, compromise and finally and forever resolve all disputes
The company has entered into above Memo to settle, compromise and finally and forever resolve all disputes
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
Built on the Percept Platform and enhanced with BrainSense technology, the system can adjust stimulation levels in real time, responding to brain signals without manual intervention
The SNS records neural activity from 60 channels across four brain regions—far exceeding current commercial devices
This approval is based on positive results from two Phase 3, global, double-blind, placebo-controlled trials
She has held senior positions at Coca-Cola in China and PepsiCo in India
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
Acute therapies continue to report strong growth compared to chronic ones.
Subscribe To Our Newsletter & Stay Updated
